Chemical Structure : Tegatrabetan
CAS No.: 1227637-23-1
Catalog No.: PC-61288Not For Human Use, Lab Use Only.
Tegatrabetan (BC-2059, BC2059, Tegavivint) is an orally bioavailable β-catenin antagonist that disrupts the binding of β-catenin to TBL1 and promotes β-catenin degradation, attenuates nuclear and cytoplasmic levels of β-catenin.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $128 | In stock | |
10 mg | $188 | In stock | |
25 mg | $298 | In stock | |
50 mg | $498 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Tegatrabetan (BC-2059, BC2059, Tegavivint) is an orally bioavailable β-catenin antagonist that disrupts the binding of β-catenin to TBL1 and promotes β-catenin degradation, attenuates nuclear and cytoplasmic levels of β-catenin.
BC-2059 reduces transcriptional activity of TCF4 and expression of its target genes, cyclin D1, c-MYC and survivin.
BC-2059 treatment dose-dependently induced apoptosis of cultured and primary AML BPCs.
BC-2059 significantly improves the median survival of immune-depleted mice engrafted with either cultured or primary AML BPCs.
M.Wt | 588.74 | |
Formula | C28H36N4O6S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
9,10-Anthracenedione, 2,7-bis[[(3R,5S)-3,5-dimethyl-1-piperidinyl]sulfonyl]-, 9,10-dioxime, rel- |
1. Fiskus W, et al. Leukemia. 2015 Jun;29(6):1267-78.
2. Savvidou I, et al. Mol Cancer Ther. 2017 Sep;16(9):1765-1778.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright